Thousands of Dutch patients are facing a 10-month supply gap for medically essential Bedrocan products, including varieties clinicians consider irreplaceable for children with treatment-resistant ...

Irish active-ingredient manufacturer Dunbar Pharmaceuticals has launched the UK’s first plant-derived dronabinol oral spray, extending a pharma-grade THC line that reached specialist prescribers in ...

Germany’s coalition government has retreated further on its controversial medical cannabis reimbursement reforms as it faces mounting questions over how and why the law came to be. A swathe of ...

Bedrocan, the Dutch medical cannabis stalwart thousands of patients rely on for their prescriptions, is now fighting to avoid collapse. This week, Bedrocan’s two Dutch entities, Bedrocan Nederland B.V ...

Is cannabis legal in Spain? No, not on paper, and in practice it remains a grey area. Private possession and consumption fall outside Spain’s Penal Code through a judicial interpretation gap, not ...

James Duckenfield, CEO of Glass Pharms ®, dives into the responsibilities behind a medical cannabis brand and why pharmaceutical standards should matter more than marketing. From cultivation controls ...

The highly anticipated Advisory Council on the Misuse of Drugs (ACMD) review into the UK’s medical cannabis framework has, for the first time, received a new target publication date. In an update to ...

James Duckenfield, CEO of Glass Pharms®, explains why we may be underestimating the pharmaceutical potential of cannabis, and how research, formulation… ...

Dr Nickel Dittrich is Managing Director of GMPion, a Berlin-based EU-GMP consultancy. Before founding GMPion, he spent more than five years at Cantourage, where he led the EU-GMP audit process for ...

Initial findings from the Netherlands’ landmark ‘controlled cannabis supply chain experiment’ were submitted to the House of Representatives on September 9, the first published findings since the T0 ...

A Michigan breach-of-contract dispute between cultivator Hello Farms and Curaleaf Holdings has cracked open a fault line that runs beneath every cannabis contract in the US, opening the door to a ...

Pressure is piling on the UK’s Advisory Council on the Misuse of Drugs (ACMD) to publish its highly anticipated review of the country’s medical cannabis framework. The Home Office-commissioned review ...